Stay current with the latest press releases from within the industry.
Release issued 24th April 2008
Israeli medical device company, aespironics Ltd., has just completed a laboratory demonstration of its novel inhaler technology. This technology is capable of delivering very high emitted dose and fine-particle fractions. The laboratory trials focused on collecting emitted dose statistics. From the results attained it was seen that the product can deliver the entire dose in a consistent fashion.
If you want to find out more about the company visit aespironics Ltd profile.